Inventor · disambiguated record
Anke Kretz-Rommel
Also filed as: KRETZ-ROMMEL ANKE
14 granted patents·20 pending applications·188 citations·filing 2002–2024
93Inventor score
Files withBOWDISH KATHERINE S13ALEXION PHARMA INC8BIRD ROCK BIO INC5ANAPHORE INC4BIRD ROCK BIO SUB INC2
Top patents by PatentIndex Score
34 records- 0196US8114403B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2010·Granted Feb 14, 2012·23 cites·3 claims
- 0294US8075884B2Antibodies to OX-2/CD200 and uses thereofBOWDISH KATHERINE S·Filed 2007·Granted Dec 13, 2011·41 cites·26 claims
- 0394US7408041B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2004·Granted Aug 5, 2008·39 cites·16 claims
- 0493US8709415B2Antibodies to OX-2/CD200 and uses thereofBOWDISH KATHERINE S·Filed 2011·Granted Apr 29, 2014·24 cites·42 claims
- 0591US7915000B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2007·Granted Mar 29, 2011·11 cites·9 claims
- 0691US7598353B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2008·Granted Oct 6, 2009·10 cites·13 claims
- 0790US9150661B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2012·Granted Oct 6, 2015·7 cites·7 claims
- 0890US8999328B2Polypeptides and antibodies derived from chronic lymphocytic Leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2011·Granted Apr 7, 2015·7 cites·2 claims
- 0988US7714110B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2008·Granted May 11, 2010·8 cites·17 claims
- 1085US9000133B2Antibodies to OX-2/CD200 and uses thereofALEXION PHARMA INC·Filed 2013·Granted Apr 7, 2015·6 cites·30 claims
- 1182US11566069B2Treatment of disease responsive to modulation of cannabanoid 1(CB1) receptor signalingBIRD ROCK BIO INC·Filed 2019·Granted Jan 31, 2023·2 cites·17 claims
- 1282US2025236669A1Antibodies That Bind Human Cannabinoid 1 (CB1) ReceptorBIRD ROCK BIO SUB INC·Filed 2024·Application pending·0 cites
- 1378US11421026B2Antibodies that bind human cannabinoid 1 (CB1) receptorBIRD ROCK BIO INC·Filed 2016·Granted Aug 23, 2022·2 cites·26 claims
- 1476US10308712B2Antibodies that bind human cannabinoid 1 (CB1) receptorBIRD ROCK BIO INC·Filed 2015·Granted Jun 4, 2019·2 cites·9 claims
- 1576US2023348589A1Antibodies That Bind Human Cannabinoid 1 (CB1) ReceptorBIRD ROCK BIO INC·Filed 2023·Application pending·0 cites
- 1668US2023159634A1Antibodies that bind human cannabinoid 1 (cb1) receptorBIRD ROCK BIO INC·Filed 2022·Application pending·0 cites
- 1767US9249229B2Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2004·Granted Feb 2, 2016·6 cites·15 claims
- 1864US2006280679A1Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cellsBOWDISH KATHERINE S·Filed 2004·Application pending·0 cites
- 1959US2025243270A1Prediction and treatment of fast progressing renal diseaseBIRD ROCK BIO SUB INC·Filed 2023·Application pending·0 cites
- 2057US2010028995A1Tetranectin Trimerizing PolypeptidesANAPHORE INC·Filed 2009·Application pending·0 cites
- 2157US2010105620A1Polypeptides that bind Trail-R1 and Trail-R2ANAPHORE INC·Filed 2009·Application pending·0 cites
- 2257US2006057651A1Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofBOWDISH KATHERINE S·Filed 2005·Application pending·0 cites
- 2356US2007054378A1Elicitation of antibodies to self peptides in mice by immunization with dendritic cellsALEXION PHARMA INC·Filed 2004·Application pending·0 cites
- 2455US2005208627A1Elicitation of antibodies to self peptides in mice by immunization with dendritic cellsBOWDISH KATHERINE S·Filed 2004·Application pending·0 cites
- 2551US2012107301A1Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cellsBOWDISH KATHERINE S·Filed 2011·Application pending·0 cites
- 2651US2015368341A1Polypeptides and antibodies derived from chronic lymphocytic leukemia cells and uses thereofALEXION PHARMA INC·Filed 2015·Application pending·0 cites
- 2749US2003219839A1Anti-PDGF antibodies and methods for producing engineered antibodiesFiled 2002·Application pending·0 cites
- 2848US2008025913A1Novel Anti-Dc-Sign AntibodiesBOWDISH KATHERINE S·Filed 2004·Application pending·0 cites
- 2947US2008152648A1Compositions and methods for enhancing an adjuvantALEXION PHARMA INC·Filed 2007·Application pending·0 cites
- 3045US2012135938A1Polypeptides that Bind TRAIL-R1 and TRAIL-R2BOWDISH KATHERINE S·Filed 2012·Application pending·0 cites
- 3141US2005281828A1Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cellsBOWDISH KATHERINE S·Filed 2005·Application pending·0 cites
- 3240US2012021995A1Polypeptides that Bind TRAIL-R1 and TRAIL-R2BOWDISH KATHERINE·Filed 2011·Application pending·0 cites
- 3333US2011086770A1Combinatorial Libraries Based on C-type Lectin-like DomainANAPHORE INC·Filed 2010·Application pending·0 cites
- 3433US2011086806A1Polypeptides that Bind IL-23RANAPHORE INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anke Kretz-Rommel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →